,question,contexts,answer,ground_truths,context_precision,faithfulness,answer_relevancy,context_recall,context_relevancy,answer_correctness,answer_similarity
0,What is the patient's age?,"['Patient recorded as having No Known Allergies to Drugs|None|64 year old male with Hx of cirrhosis  NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy. Pt was found to have a temp of 99.6 at nursing home on day of admission. the family also thought that the pt was lethargic and may be w/ AMS. he recd tylenol at NH and his temp came down to 98.6. He was brought to the ER . In the ER VS 98.9 81 116/63 16 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. .|Remote tobacco history.  No alcohol or illicit drug use. Currently resides at  Nursing Home.|PHYSICAL EXAMINATION: VS: 98.2 150/75 87 22 93/3l GEN: NAD, awake, alert HEENT: EOMI, PERRL, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple, no JVD CV: Reg rate, normal S1, S2. No m/r/g. CHEST: b/l wheezes and rhonchi. ABD: Soft, NT, ND, no HSM EXT: No c/c/e SKIN: maculopapular rash on back|IMPRESSION: No evidence of hemorrhage seen. Appearance of the brain is unchanged from . Opacification of visualized right maxillary sinus unchanged.|GRAYSCALE IMAGING: The liver demonstrates a heterogeneous echotexture without focal mass lesion detected on this limited evaluation of the hepatic parenchyma. No intra- or extra-hepatic biliary ductal dilatation with the common duct measuring 3 mm. The gallbladder appears unremarkable, without wall thickening or pericholecystic fluid/intraluminal stone. There is splenomegaly with the spleen measuring 17.6 cm. No intra-abdominal ascites. DOPPLER EXAMINATION: Color and pulsed pulse-wave Doppler images were obtained. The main portal vein is patent with normal hepatopetal flow with a velocity of 22 cm/sec. The TIPS shunt is patent with wall-to-wall flow. Velocities of 27, 90 and 94 cm/sec. The splenic vein and SMV are patent. IVC demonstrates patency with triphasic waveforms. IMPRESSION: Normal TIPS evaluation with wall-to-wall flow. No ascites identified.|# Respiratory failure:  The patient developed respiratory failure during seziure activity and recent HCAP.  He was intubated for airway protection and sent to the MICU.  He was able to be extubated days later without difficulty.  The patient was treated with lasix for diuresis.  Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course.|He was evaluated by pulmonary who felt his tachypnea was likely due to fluid overload. He was diuresed and his respiratory status later stabilized. No further bronchoscopy was recommended as it was unlikely that he laryngeal/tracheal stenosis given his clinical improvement with diuresis. . #Seizure disorder:  The patient has a known seizure disorder and hx of NCSE.  He again had continuous seizure activity documented by continous EEG monitoring.  His home regimen of keppra, zonegran and topamax was increased and ativan, dilantin were added to the regimen. He required dilantin loading on two occassions. His seizures were eventually well controlled and the ativan was weaned off without seizure recurrence under EEG monitoring. His mental status started to improve signficantly and at discharge, he was answering questions briskly, able to state the place but did not know the date, and was eager to leave the hospital. . # Cirrhosis: Secondary to NASH.  During his hospital stay his LFTs/bili and coags remained stable.  He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.  He was continued on lactulose and rifaxamin. . #. Stage IV sacral decub:  No evidence of osteomyelitis per X-ray.  Wound care consulted and recommended daily packing. . #DM: The patient was temporarily taken off home lantus as had episodes of hypoglycemia.  He was restarted on his home dose of lantus without problem. . #Hypothyroidism: continued home levothyroxine . # Hypernatremia:  The patient became transiently hypernatremic during his MICU course.  Free water boluses were increased through his tube feeds.  The hypernatremia resolved. . # CAD: stress MIBI in  w/ Fixed, medium sized, severe perfusion defect involving the PDA territory.  Increased left ventricular cavity size. Inferior hypokinesis with preserved systolic function.  No recent h/o chest pain.  Most recent echo with improved EF. . # Pancytopenia:  Chronic issue, likely BM suppression or secondary to seizure medications.  Trended, remained stable. . #FEN:  tube feeds, repleted electrolytes prn, free H20 boluses through tube feeds. #PPX: PPI, lactulose, pneumoboots (no heparin sq given low platelets), aspiration precautions, contact  #: Full Code #Communication: with wife  (-home) and -cell)|One (1) Tablet PO DAILY (Daily).|. Ascorbic Acid 500 mg Tablet : One (1) Tablet PO BID (2 times a day).|. Zinc Sulfate 220 mg Capsule : One (1) Capsule PO DAILY (Daily).|. Aspirin 325 mg Tablet : One (1) Tablet PO DAILY (Daily).|. Oxycodone 5 mg Tablet : 0.5 Tablet PO Q6H (every 6 hours) as needed: before sacral ulcer dressing.|0. Nystatin 100,000 unit/mL Suspension : Five (5) ML PO TID (3 times a day).|1. Lansoprazole 30 mg Tablet,Rapid Dissolve, DR : One (1) Tablet,Rapid Dissolve, DR  DAILY (Daily).|2. Miconazole Nitrate 2 % Powder : One (1) Appl Topical TID (3 times a day) as needed for tinea cruris.|3. Levetiracetam 1,000 mg Tablet : Two (2) Tablet PO BID (2 times a day).|4. Keppra 250 mg Tablet : One (1) Tablet PO twice a day.|5. Zonisamide 100 mg Capsule : Six (6) Capsule PO DAILY (Daily).|6. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization : One (1) neb Inhalation Q4H (every 4 hours) as needed for wheeze.|7. Ipratropium Bromide 0.02 % Solution : One (1) neb Inhalation Q6H (every 6 hours) as needed for wheeze.|8. Erythromycin 5 mg/g Ointment : One (1) application Ophthalmic QID (4 times a day).|9. Lactulose 10 gram/15 mL Syrup : Fifteen (15) ML PO TID (3 times a day): titrate to  BM per day.|0. Phenytoin 50 mg Tablet, Chewable : Four (4) Tablet, Chewable PO DAILY (Daily): Give in AM.|1. Phenytoin 50 mg Tablet, Chewable : Six (6) Tablet, Chewable PO DAILY (Daily): Give 8 pm.|2. Topiramate 100 mg Tablet : Three (3) Tablet PO BID (2 times a day).|3. Povidone-Iodine 10 % Solution : One (1) Appl Topical DAILY (Daily): apply to PEG tube insertion site.|4. Insulin Glargine 100 unit/mL Cartridge : Thirty Eight (38) Units Subcutaneous at bedtime.|5. Insulin Regular Human 300 unit/3 mL Insulin Pen : 11-32 units  Subcutaneous three times a day: Per sliding scale: FS 71-100, 11 Units FS 101-150, 17 Units FS 151-200, 20 Units FS 201-250, 24 Units FS 251-300, 28 Units FS 301-350, 32 Units.|increased seizure frequency in the context of PNA|NASH DM refractory seizures recurrent hepatic encephalopathy|stable; baseline MS difficulty with some memory and attention deficits. Distal extremity contractures, and asteryxis.|You were admitted with worsening seizures and mental status in the context of acquiring a pneumonia. You required temporary intubation and were treated with antibiotics. Your seizures were controlled with a combination of anti-epileptic medicines, which you should continue. Please return to the ER if you experiece any worsening of your seizure frequency, develop new types of seizures, develop changes in mental status, weakness, changes in sensation, vision, or language, and severe headaches, vertigo, or anything else that concerns you seriously.|Follow up with neurologist Dr.  ; call ( for appt']",64 year old,['64'],0.0,1.0,0.9144031269666458,1.0,0.007936507936507936,1.0,True
1,Did the patient have any allergies to drugs?,"['Patient recorded as having No Known Allergies to Drugs|None|64 year old male with Hx of cirrhosis  NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy. Pt was found to have a temp of 99.6 at nursing home on day of admission. the family also thought that the pt was lethargic and may be w/ AMS. he recd tylenol at NH and his temp came down to 98.6. He was brought to the ER . In the ER VS 98.9 81 116/63 16 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. .|Remote tobacco history.  No alcohol or illicit drug use. Currently resides at  Nursing Home.|PHYSICAL EXAMINATION: VS: 98.2 150/75 87 22 93/3l GEN: NAD, awake, alert HEENT: EOMI, PERRL, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple, no JVD CV: Reg rate, normal S1, S2. No m/r/g. CHEST: b/l wheezes and rhonchi. ABD: Soft, NT, ND, no HSM EXT: No c/c/e SKIN: maculopapular rash on back|IMPRESSION: No evidence of hemorrhage seen. Appearance of the brain is unchanged from . Opacification of visualized right maxillary sinus unchanged.|GRAYSCALE IMAGING: The liver demonstrates a heterogeneous echotexture without focal mass lesion detected on this limited evaluation of the hepatic parenchyma. No intra- or extra-hepatic biliary ductal dilatation with the common duct measuring 3 mm. The gallbladder appears unremarkable, without wall thickening or pericholecystic fluid/intraluminal stone. There is splenomegaly with the spleen measuring 17.6 cm. No intra-abdominal ascites. DOPPLER EXAMINATION: Color and pulsed pulse-wave Doppler images were obtained. The main portal vein is patent with normal hepatopetal flow with a velocity of 22 cm/sec. The TIPS shunt is patent with wall-to-wall flow. Velocities of 27, 90 and 94 cm/sec. The splenic vein and SMV are patent. IVC demonstrates patency with triphasic waveforms. IMPRESSION: Normal TIPS evaluation with wall-to-wall flow. No ascites identified.|# Respiratory failure:  The patient developed respiratory failure during seziure activity and recent HCAP.  He was intubated for airway protection and sent to the MICU.  He was able to be extubated days later without difficulty.  The patient was treated with lasix for diuresis.  Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course.|He was evaluated by pulmonary who felt his tachypnea was likely due to fluid overload. He was diuresed and his respiratory status later stabilized. No further bronchoscopy was recommended as it was unlikely that he laryngeal/tracheal stenosis given his clinical improvement with diuresis. . #Seizure disorder:  The patient has a known seizure disorder and hx of NCSE.  He again had continuous seizure activity documented by continous EEG monitoring.  His home regimen of keppra, zonegran and topamax was increased and ativan, dilantin were added to the regimen. He required dilantin loading on two occassions. His seizures were eventually well controlled and the ativan was weaned off without seizure recurrence under EEG monitoring. His mental status started to improve signficantly and at discharge, he was answering questions briskly, able to state the place but did not know the date, and was eager to leave the hospital. . # Cirrhosis: Secondary to NASH.  During his hospital stay his LFTs/bili and coags remained stable.  He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.  He was continued on lactulose and rifaxamin. . #. Stage IV sacral decub:  No evidence of osteomyelitis per X-ray.  Wound care consulted and recommended daily packing. . #DM: The patient was temporarily taken off home lantus as had episodes of hypoglycemia.  He was restarted on his home dose of lantus without problem. . #Hypothyroidism: continued home levothyroxine . # Hypernatremia:  The patient became transiently hypernatremic during his MICU course.  Free water boluses were increased through his tube feeds.  The hypernatremia resolved. . # CAD: stress MIBI in  w/ Fixed, medium sized, severe perfusion defect involving the PDA territory.  Increased left ventricular cavity size. Inferior hypokinesis with preserved systolic function.  No recent h/o chest pain.  Most recent echo with improved EF. . # Pancytopenia:  Chronic issue, likely BM suppression or secondary to seizure medications.  Trended, remained stable. . #FEN:  tube feeds, repleted electrolytes prn, free H20 boluses through tube feeds. #PPX: PPI, lactulose, pneumoboots (no heparin sq given low platelets), aspiration precautions, contact  #: Full Code #Communication: with wife  (-home) and -cell)|One (1) Tablet PO DAILY (Daily).|. Ascorbic Acid 500 mg Tablet : One (1) Tablet PO BID (2 times a day).|. Zinc Sulfate 220 mg Capsule : One (1) Capsule PO DAILY (Daily).|. Aspirin 325 mg Tablet : One (1) Tablet PO DAILY (Daily).|. Oxycodone 5 mg Tablet : 0.5 Tablet PO Q6H (every 6 hours) as needed: before sacral ulcer dressing.|0. Nystatin 100,000 unit/mL Suspension : Five (5) ML PO TID (3 times a day).|1. Lansoprazole 30 mg Tablet,Rapid Dissolve, DR : One (1) Tablet,Rapid Dissolve, DR  DAILY (Daily).|2. Miconazole Nitrate 2 % Powder : One (1) Appl Topical TID (3 times a day) as needed for tinea cruris.|3. Levetiracetam 1,000 mg Tablet : Two (2) Tablet PO BID (2 times a day).|4. Keppra 250 mg Tablet : One (1) Tablet PO twice a day.|5. Zonisamide 100 mg Capsule : Six (6) Capsule PO DAILY (Daily).|6. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization : One (1) neb Inhalation Q4H (every 4 hours) as needed for wheeze.|7. Ipratropium Bromide 0.02 % Solution : One (1) neb Inhalation Q6H (every 6 hours) as needed for wheeze.|8. Erythromycin 5 mg/g Ointment : One (1) application Ophthalmic QID (4 times a day).|9. Lactulose 10 gram/15 mL Syrup : Fifteen (15) ML PO TID (3 times a day): titrate to  BM per day.|0. Phenytoin 50 mg Tablet, Chewable : Four (4) Tablet, Chewable PO DAILY (Daily): Give in AM.|1. Phenytoin 50 mg Tablet, Chewable : Six (6) Tablet, Chewable PO DAILY (Daily): Give 8 pm.|2. Topiramate 100 mg Tablet : Three (3) Tablet PO BID (2 times a day).|3. Povidone-Iodine 10 % Solution : One (1) Appl Topical DAILY (Daily): apply to PEG tube insertion site.|4. Insulin Glargine 100 unit/mL Cartridge : Thirty Eight (38) Units Subcutaneous at bedtime.|5. Insulin Regular Human 300 unit/3 mL Insulin Pen : 11-32 units  Subcutaneous three times a day: Per sliding scale: FS 71-100, 11 Units FS 101-150, 17 Units FS 151-200, 20 Units FS 201-250, 24 Units FS 251-300, 28 Units FS 301-350, 32 Units.|increased seizure frequency in the context of PNA|NASH DM refractory seizures recurrent hepatic encephalopathy|stable; baseline MS difficulty with some memory and attention deficits. Distal extremity contractures, and asteryxis.|You were admitted with worsening seizures and mental status in the context of acquiring a pneumonia. You required temporary intubation and were treated with antibiotics. Your seizures were controlled with a combination of anti-epileptic medicines, which you should continue. Please return to the ER if you experiece any worsening of your seizure frequency, develop new types of seizures, develop changes in mental status, weakness, changes in sensation, vision, or language, and severe headaches, vertigo, or anything else that concerns you seriously.|Follow up with neurologist Dr.  ; call ( for appt']","No, he was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course. He was intubated for airway protection and sent to the MICU. He was intubated for airway protection and sent to the MICU. He was intubated for airway protection and sent to the MICU. He was intubated for airway protection and sent to the MICU. He was temporarily taken off home lantus as had episodes of hypoglycemia. He was restarted on his home dose of lantus without problem. He was treated with lasix for diuresis. Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn, and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course. He recd tylenol at NH and his temp came down to 98.6. He was brought to the ER VS 98.9 81 116/63 16 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. . |Document (page_content='Patient recorded as having No Known Allergies to Drugs|None|64 year old male with Hx of cirrhosis NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy. Pt was found to have a temp of 99.6 at nursing home on day of admission. the family also thought the pt was lethargic and may be w/ AMS. he recd tylenol at NH and his temp came down to 98.6. He was brought to the ER VS 98.9 81 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. . |","['No,he recorded as having No Known Allergies to Drugs.']",0.9999999999,0.7,0.8380870798782593,1.0,0.007936507936507936,0.6818181818181819,True
2,What was the temperature of the patient at nursing home?,"['Patient recorded as having No Known Allergies to Drugs|None|64 year old male with Hx of cirrhosis  NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy. Pt was found to have a temp of 99.6 at nursing home on day of admission. the family also thought that the pt was lethargic and may be w/ AMS. he recd tylenol at NH and his temp came down to 98.6. He was brought to the ER . In the ER VS 98.9 81 116/63 16 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. .|Remote tobacco history.  No alcohol or illicit drug use. Currently resides at  Nursing Home.|PHYSICAL EXAMINATION: VS: 98.2 150/75 87 22 93/3l GEN: NAD, awake, alert HEENT: EOMI, PERRL, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple, no JVD CV: Reg rate, normal S1, S2. No m/r/g. CHEST: b/l wheezes and rhonchi. ABD: Soft, NT, ND, no HSM EXT: No c/c/e SKIN: maculopapular rash on back|IMPRESSION: No evidence of hemorrhage seen. Appearance of the brain is unchanged from . Opacification of visualized right maxillary sinus unchanged.|GRAYSCALE IMAGING: The liver demonstrates a heterogeneous echotexture without focal mass lesion detected on this limited evaluation of the hepatic parenchyma. No intra- or extra-hepatic biliary ductal dilatation with the common duct measuring 3 mm. The gallbladder appears unremarkable, without wall thickening or pericholecystic fluid/intraluminal stone. There is splenomegaly with the spleen measuring 17.6 cm. No intra-abdominal ascites. DOPPLER EXAMINATION: Color and pulsed pulse-wave Doppler images were obtained. The main portal vein is patent with normal hepatopetal flow with a velocity of 22 cm/sec. The TIPS shunt is patent with wall-to-wall flow. Velocities of 27, 90 and 94 cm/sec. The splenic vein and SMV are patent. IVC demonstrates patency with triphasic waveforms. IMPRESSION: Normal TIPS evaluation with wall-to-wall flow. No ascites identified.|# Respiratory failure:  The patient developed respiratory failure during seziure activity and recent HCAP.  He was intubated for airway protection and sent to the MICU.  He was able to be extubated days later without difficulty.  The patient was treated with lasix for diuresis.  Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course.|He was evaluated by pulmonary who felt his tachypnea was likely due to fluid overload. He was diuresed and his respiratory status later stabilized. No further bronchoscopy was recommended as it was unlikely that he laryngeal/tracheal stenosis given his clinical improvement with diuresis. . #Seizure disorder:  The patient has a known seizure disorder and hx of NCSE.  He again had continuous seizure activity documented by continous EEG monitoring.  His home regimen of keppra, zonegran and topamax was increased and ativan, dilantin were added to the regimen. He required dilantin loading on two occassions. His seizures were eventually well controlled and the ativan was weaned off without seizure recurrence under EEG monitoring. His mental status started to improve signficantly and at discharge, he was answering questions briskly, able to state the place but did not know the date, and was eager to leave the hospital. . # Cirrhosis: Secondary to NASH.  During his hospital stay his LFTs/bili and coags remained stable.  He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.  He was continued on lactulose and rifaxamin. . #. Stage IV sacral decub:  No evidence of osteomyelitis per X-ray.  Wound care consulted and recommended daily packing. . #DM: The patient was temporarily taken off home lantus as had episodes of hypoglycemia.  He was restarted on his home dose of lantus without problem. . #Hypothyroidism: continued home levothyroxine . # Hypernatremia:  The patient became transiently hypernatremic during his MICU course.  Free water boluses were increased through his tube feeds.  The hypernatremia resolved. . # CAD: stress MIBI in  w/ Fixed, medium sized, severe perfusion defect involving the PDA territory.  Increased left ventricular cavity size. Inferior hypokinesis with preserved systolic function.  No recent h/o chest pain.  Most recent echo with improved EF. . # Pancytopenia:  Chronic issue, likely BM suppression or secondary to seizure medications.  Trended, remained stable. . #FEN:  tube feeds, repleted electrolytes prn, free H20 boluses through tube feeds. #PPX: PPI, lactulose, pneumoboots (no heparin sq given low platelets), aspiration precautions, contact  #: Full Code #Communication: with wife  (-home) and -cell)|One (1) Tablet PO DAILY (Daily).|. Ascorbic Acid 500 mg Tablet : One (1) Tablet PO BID (2 times a day).|. Zinc Sulfate 220 mg Capsule : One (1) Capsule PO DAILY (Daily).|. Aspirin 325 mg Tablet : One (1) Tablet PO DAILY (Daily).|. Oxycodone 5 mg Tablet : 0.5 Tablet PO Q6H (every 6 hours) as needed: before sacral ulcer dressing.|0. Nystatin 100,000 unit/mL Suspension : Five (5) ML PO TID (3 times a day).|1. Lansoprazole 30 mg Tablet,Rapid Dissolve, DR : One (1) Tablet,Rapid Dissolve, DR  DAILY (Daily).|2. Miconazole Nitrate 2 % Powder : One (1) Appl Topical TID (3 times a day) as needed for tinea cruris.|3. Levetiracetam 1,000 mg Tablet : Two (2) Tablet PO BID (2 times a day).|4. Keppra 250 mg Tablet : One (1) Tablet PO twice a day.|5. Zonisamide 100 mg Capsule : Six (6) Capsule PO DAILY (Daily).|6. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization : One (1) neb Inhalation Q4H (every 4 hours) as needed for wheeze.|7. Ipratropium Bromide 0.02 % Solution : One (1) neb Inhalation Q6H (every 6 hours) as needed for wheeze.|8. Erythromycin 5 mg/g Ointment : One (1) application Ophthalmic QID (4 times a day).|9. Lactulose 10 gram/15 mL Syrup : Fifteen (15) ML PO TID (3 times a day): titrate to  BM per day.|0. Phenytoin 50 mg Tablet, Chewable : Four (4) Tablet, Chewable PO DAILY (Daily): Give in AM.|1. Phenytoin 50 mg Tablet, Chewable : Six (6) Tablet, Chewable PO DAILY (Daily): Give 8 pm.|2. Topiramate 100 mg Tablet : Three (3) Tablet PO BID (2 times a day).|3. Povidone-Iodine 10 % Solution : One (1) Appl Topical DAILY (Daily): apply to PEG tube insertion site.|4. Insulin Glargine 100 unit/mL Cartridge : Thirty Eight (38) Units Subcutaneous at bedtime.|5. Insulin Regular Human 300 unit/3 mL Insulin Pen : 11-32 units  Subcutaneous three times a day: Per sliding scale: FS 71-100, 11 Units FS 101-150, 17 Units FS 151-200, 20 Units FS 201-250, 24 Units FS 251-300, 28 Units FS 301-350, 32 Units.|increased seizure frequency in the context of PNA|NASH DM refractory seizures recurrent hepatic encephalopathy|stable; baseline MS difficulty with some memory and attention deficits. Distal extremity contractures, and asteryxis.|You were admitted with worsening seizures and mental status in the context of acquiring a pneumonia. You required temporary intubation and were treated with antibiotics. Your seizures were controlled with a combination of anti-epileptic medicines, which you should continue. Please return to the ER if you experiece any worsening of your seizure frequency, develop new types of seizures, develop changes in mental status, weakness, changes in sensation, vision, or language, and severe headaches, vertigo, or anything else that concerns you seriously.|Follow up with neurologist Dr.  ; call ( for appt']",98.6,['99.6'],0.0,1.0,0.8448935642778562,1.0,0.007936507936507936,0.5,True
3,What findings were noted on the CXR?,"['Patient recorded as having No Known Allergies to Drugs|None|64 year old male with Hx of cirrhosis  NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy. Pt was found to have a temp of 99.6 at nursing home on day of admission. the family also thought that the pt was lethargic and may be w/ AMS. he recd tylenol at NH and his temp came down to 98.6. He was brought to the ER . In the ER VS 98.9 81 116/63 16 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. .|Remote tobacco history.  No alcohol or illicit drug use. Currently resides at  Nursing Home.|PHYSICAL EXAMINATION: VS: 98.2 150/75 87 22 93/3l GEN: NAD, awake, alert HEENT: EOMI, PERRL, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple, no JVD CV: Reg rate, normal S1, S2. No m/r/g. CHEST: b/l wheezes and rhonchi. ABD: Soft, NT, ND, no HSM EXT: No c/c/e SKIN: maculopapular rash on back|IMPRESSION: No evidence of hemorrhage seen. Appearance of the brain is unchanged from . Opacification of visualized right maxillary sinus unchanged.|GRAYSCALE IMAGING: The liver demonstrates a heterogeneous echotexture without focal mass lesion detected on this limited evaluation of the hepatic parenchyma. No intra- or extra-hepatic biliary ductal dilatation with the common duct measuring 3 mm. The gallbladder appears unremarkable, without wall thickening or pericholecystic fluid/intraluminal stone. There is splenomegaly with the spleen measuring 17.6 cm. No intra-abdominal ascites. DOPPLER EXAMINATION: Color and pulsed pulse-wave Doppler images were obtained. The main portal vein is patent with normal hepatopetal flow with a velocity of 22 cm/sec. The TIPS shunt is patent with wall-to-wall flow. Velocities of 27, 90 and 94 cm/sec. The splenic vein and SMV are patent. IVC demonstrates patency with triphasic waveforms. IMPRESSION: Normal TIPS evaluation with wall-to-wall flow. No ascites identified.|# Respiratory failure:  The patient developed respiratory failure during seziure activity and recent HCAP.  He was intubated for airway protection and sent to the MICU.  He was able to be extubated days later without difficulty.  The patient was treated with lasix for diuresis.  Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course.|He was evaluated by pulmonary who felt his tachypnea was likely due to fluid overload. He was diuresed and his respiratory status later stabilized. No further bronchoscopy was recommended as it was unlikely that he laryngeal/tracheal stenosis given his clinical improvement with diuresis. . #Seizure disorder:  The patient has a known seizure disorder and hx of NCSE.  He again had continuous seizure activity documented by continous EEG monitoring.  His home regimen of keppra, zonegran and topamax was increased and ativan, dilantin were added to the regimen. He required dilantin loading on two occassions. His seizures were eventually well controlled and the ativan was weaned off without seizure recurrence under EEG monitoring. His mental status started to improve signficantly and at discharge, he was answering questions briskly, able to state the place but did not know the date, and was eager to leave the hospital. . # Cirrhosis: Secondary to NASH.  During his hospital stay his LFTs/bili and coags remained stable.  He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.  He was continued on lactulose and rifaxamin. . #. Stage IV sacral decub:  No evidence of osteomyelitis per X-ray.  Wound care consulted and recommended daily packing. . #DM: The patient was temporarily taken off home lantus as had episodes of hypoglycemia.  He was restarted on his home dose of lantus without problem. . #Hypothyroidism: continued home levothyroxine . # Hypernatremia:  The patient became transiently hypernatremic during his MICU course.  Free water boluses were increased through his tube feeds.  The hypernatremia resolved. . # CAD: stress MIBI in  w/ Fixed, medium sized, severe perfusion defect involving the PDA territory.  Increased left ventricular cavity size. Inferior hypokinesis with preserved systolic function.  No recent h/o chest pain.  Most recent echo with improved EF. . # Pancytopenia:  Chronic issue, likely BM suppression or secondary to seizure medications.  Trended, remained stable. . #FEN:  tube feeds, repleted electrolytes prn, free H20 boluses through tube feeds. #PPX: PPI, lactulose, pneumoboots (no heparin sq given low platelets), aspiration precautions, contact  #: Full Code #Communication: with wife  (-home) and -cell)|One (1) Tablet PO DAILY (Daily).|. Ascorbic Acid 500 mg Tablet : One (1) Tablet PO BID (2 times a day).|. Zinc Sulfate 220 mg Capsule : One (1) Capsule PO DAILY (Daily).|. Aspirin 325 mg Tablet : One (1) Tablet PO DAILY (Daily).|. Oxycodone 5 mg Tablet : 0.5 Tablet PO Q6H (every 6 hours) as needed: before sacral ulcer dressing.|0. Nystatin 100,000 unit/mL Suspension : Five (5) ML PO TID (3 times a day).|1. Lansoprazole 30 mg Tablet,Rapid Dissolve, DR : One (1) Tablet,Rapid Dissolve, DR  DAILY (Daily).|2. Miconazole Nitrate 2 % Powder : One (1) Appl Topical TID (3 times a day) as needed for tinea cruris.|3. Levetiracetam 1,000 mg Tablet : Two (2) Tablet PO BID (2 times a day).|4. Keppra 250 mg Tablet : One (1) Tablet PO twice a day.|5. Zonisamide 100 mg Capsule : Six (6) Capsule PO DAILY (Daily).|6. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization : One (1) neb Inhalation Q4H (every 4 hours) as needed for wheeze.|7. Ipratropium Bromide 0.02 % Solution : One (1) neb Inhalation Q6H (every 6 hours) as needed for wheeze.|8. Erythromycin 5 mg/g Ointment : One (1) application Ophthalmic QID (4 times a day).|9. Lactulose 10 gram/15 mL Syrup : Fifteen (15) ML PO TID (3 times a day): titrate to  BM per day.|0. Phenytoin 50 mg Tablet, Chewable : Four (4) Tablet, Chewable PO DAILY (Daily): Give in AM.|1. Phenytoin 50 mg Tablet, Chewable : Six (6) Tablet, Chewable PO DAILY (Daily): Give 8 pm.|2. Topiramate 100 mg Tablet : Three (3) Tablet PO BID (2 times a day).|3. Povidone-Iodine 10 % Solution : One (1) Appl Topical DAILY (Daily): apply to PEG tube insertion site.|4. Insulin Glargine 100 unit/mL Cartridge : Thirty Eight (38) Units Subcutaneous at bedtime.|5. Insulin Regular Human 300 unit/3 mL Insulin Pen : 11-32 units  Subcutaneous three times a day: Per sliding scale: FS 71-100, 11 Units FS 101-150, 17 Units FS 151-200, 20 Units FS 201-250, 24 Units FS 251-300, 28 Units FS 301-350, 32 Units.|increased seizure frequency in the context of PNA|NASH DM refractory seizures recurrent hepatic encephalopathy|stable; baseline MS difficulty with some memory and attention deficits. Distal extremity contractures, and asteryxis.|You were admitted with worsening seizures and mental status in the context of acquiring a pneumonia. You required temporary intubation and were treated with antibiotics. Your seizures were controlled with a combination of anti-epileptic medicines, which you should continue. Please return to the ER if you experiece any worsening of your seizure frequency, develop new types of seizures, develop changes in mental status, weakness, changes in sensation, vision, or language, and severe headaches, vertigo, or anything else that concerns you seriously.|Follow up with neurologist Dr.  ; call ( for appt']",he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd 1 dose each of vanc and cefepime. he recd,['CXR showed new LLL opacity.'],0.0,0.0,0.754461145778137,1.0,0.007936507936507936,0.5,True
4,Who was scheduled for the patient's follow-up care?,"['Patient recorded as having No Known Allergies to Drugs|None|64 year old male with Hx of cirrhosis  NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy. Pt was found to have a temp of 99.6 at nursing home on day of admission. the family also thought that the pt was lethargic and may be w/ AMS. he recd tylenol at NH and his temp came down to 98.6. He was brought to the ER . In the ER VS 98.9 81 116/63 16 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. .|Remote tobacco history.  No alcohol or illicit drug use. Currently resides at  Nursing Home.|PHYSICAL EXAMINATION: VS: 98.2 150/75 87 22 93/3l GEN: NAD, awake, alert HEENT: EOMI, PERRL, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple, no JVD CV: Reg rate, normal S1, S2. No m/r/g. CHEST: b/l wheezes and rhonchi. ABD: Soft, NT, ND, no HSM EXT: No c/c/e SKIN: maculopapular rash on back|IMPRESSION: No evidence of hemorrhage seen. Appearance of the brain is unchanged from . Opacification of visualized right maxillary sinus unchanged.|GRAYSCALE IMAGING: The liver demonstrates a heterogeneous echotexture without focal mass lesion detected on this limited evaluation of the hepatic parenchyma. No intra- or extra-hepatic biliary ductal dilatation with the common duct measuring 3 mm. The gallbladder appears unremarkable, without wall thickening or pericholecystic fluid/intraluminal stone. There is splenomegaly with the spleen measuring 17.6 cm. No intra-abdominal ascites. DOPPLER EXAMINATION: Color and pulsed pulse-wave Doppler images were obtained. The main portal vein is patent with normal hepatopetal flow with a velocity of 22 cm/sec. The TIPS shunt is patent with wall-to-wall flow. Velocities of 27, 90 and 94 cm/sec. The splenic vein and SMV are patent. IVC demonstrates patency with triphasic waveforms. IMPRESSION: Normal TIPS evaluation with wall-to-wall flow. No ascites identified.|# Respiratory failure:  The patient developed respiratory failure during seziure activity and recent HCAP.  He was intubated for airway protection and sent to the MICU.  He was able to be extubated days later without difficulty.  The patient was treated with lasix for diuresis.  Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course.|He was evaluated by pulmonary who felt his tachypnea was likely due to fluid overload. He was diuresed and his respiratory status later stabilized. No further bronchoscopy was recommended as it was unlikely that he laryngeal/tracheal stenosis given his clinical improvement with diuresis. . #Seizure disorder:  The patient has a known seizure disorder and hx of NCSE.  He again had continuous seizure activity documented by continous EEG monitoring.  His home regimen of keppra, zonegran and topamax was increased and ativan, dilantin were added to the regimen. He required dilantin loading on two occassions. His seizures were eventually well controlled and the ativan was weaned off without seizure recurrence under EEG monitoring. His mental status started to improve signficantly and at discharge, he was answering questions briskly, able to state the place but did not know the date, and was eager to leave the hospital. . # Cirrhosis: Secondary to NASH.  During his hospital stay his LFTs/bili and coags remained stable.  He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.  He was continued on lactulose and rifaxamin. . #. Stage IV sacral decub:  No evidence of osteomyelitis per X-ray.  Wound care consulted and recommended daily packing. . #DM: The patient was temporarily taken off home lantus as had episodes of hypoglycemia.  He was restarted on his home dose of lantus without problem. . #Hypothyroidism: continued home levothyroxine . # Hypernatremia:  The patient became transiently hypernatremic during his MICU course.  Free water boluses were increased through his tube feeds.  The hypernatremia resolved. . # CAD: stress MIBI in  w/ Fixed, medium sized, severe perfusion defect involving the PDA territory.  Increased left ventricular cavity size. Inferior hypokinesis with preserved systolic function.  No recent h/o chest pain.  Most recent echo with improved EF. . # Pancytopenia:  Chronic issue, likely BM suppression or secondary to seizure medications.  Trended, remained stable. . #FEN:  tube feeds, repleted electrolytes prn, free H20 boluses through tube feeds. #PPX: PPI, lactulose, pneumoboots (no heparin sq given low platelets), aspiration precautions, contact  #: Full Code #Communication: with wife  (-home) and -cell)|One (1) Tablet PO DAILY (Daily).|. Ascorbic Acid 500 mg Tablet : One (1) Tablet PO BID (2 times a day).|. Zinc Sulfate 220 mg Capsule : One (1) Capsule PO DAILY (Daily).|. Aspirin 325 mg Tablet : One (1) Tablet PO DAILY (Daily).|. Oxycodone 5 mg Tablet : 0.5 Tablet PO Q6H (every 6 hours) as needed: before sacral ulcer dressing.|0. Nystatin 100,000 unit/mL Suspension : Five (5) ML PO TID (3 times a day).|1. Lansoprazole 30 mg Tablet,Rapid Dissolve, DR : One (1) Tablet,Rapid Dissolve, DR  DAILY (Daily).|2. Miconazole Nitrate 2 % Powder : One (1) Appl Topical TID (3 times a day) as needed for tinea cruris.|3. Levetiracetam 1,000 mg Tablet : Two (2) Tablet PO BID (2 times a day).|4. Keppra 250 mg Tablet : One (1) Tablet PO twice a day.|5. Zonisamide 100 mg Capsule : Six (6) Capsule PO DAILY (Daily).|6. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization : One (1) neb Inhalation Q4H (every 4 hours) as needed for wheeze.|7. Ipratropium Bromide 0.02 % Solution : One (1) neb Inhalation Q6H (every 6 hours) as needed for wheeze.|8. Erythromycin 5 mg/g Ointment : One (1) application Ophthalmic QID (4 times a day).|9. Lactulose 10 gram/15 mL Syrup : Fifteen (15) ML PO TID (3 times a day): titrate to  BM per day.|0. Phenytoin 50 mg Tablet, Chewable : Four (4) Tablet, Chewable PO DAILY (Daily): Give in AM.|1. Phenytoin 50 mg Tablet, Chewable : Six (6) Tablet, Chewable PO DAILY (Daily): Give 8 pm.|2. Topiramate 100 mg Tablet : Three (3) Tablet PO BID (2 times a day).|3. Povidone-Iodine 10 % Solution : One (1) Appl Topical DAILY (Daily): apply to PEG tube insertion site.|4. Insulin Glargine 100 unit/mL Cartridge : Thirty Eight (38) Units Subcutaneous at bedtime.|5. Insulin Regular Human 300 unit/3 mL Insulin Pen : 11-32 units  Subcutaneous three times a day: Per sliding scale: FS 71-100, 11 Units FS 101-150, 17 Units FS 151-200, 20 Units FS 201-250, 24 Units FS 251-300, 28 Units FS 301-350, 32 Units.|increased seizure frequency in the context of PNA|NASH DM refractory seizures recurrent hepatic encephalopathy|stable; baseline MS difficulty with some memory and attention deficits. Distal extremity contractures, and asteryxis.|You were admitted with worsening seizures and mental status in the context of acquiring a pneumonia. You required temporary intubation and were treated with antibiotics. Your seizures were controlled with a combination of anti-epileptic medicines, which you should continue. Please return to the ER if you experiece any worsening of your seizure frequency, develop new types of seizures, develop changes in mental status, weakness, changes in sensation, vision, or language, and severe headaches, vertigo, or anything else that concerns you seriously.|Follow up with neurologist Dr.  ; call ( for appt']",neurologist Dr.,['neurologist Dr.'],0.0,1.0,0.7831135947165043,1.0,0.0,1.0,True
5,What measures were taken for the patient during his hospital stay?,"['Patient recorded as having No Known Allergies to Drugs|None|64 year old male with Hx of cirrhosis  NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy. Pt was found to have a temp of 99.6 at nursing home on day of admission. the family also thought that the pt was lethargic and may be w/ AMS. he recd tylenol at NH and his temp came down to 98.6. He was brought to the ER . In the ER VS 98.9 81 116/63 16 96/2L. he had a neg head CT. CXR showed new LLL opacity. he recd 1 dose each of vanc and cefepime. . ROS: ROS: Denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. .|Remote tobacco history.  No alcohol or illicit drug use. Currently resides at  Nursing Home.|PHYSICAL EXAMINATION: VS: 98.2 150/75 87 22 93/3l GEN: NAD, awake, alert HEENT: EOMI, PERRL, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple, no JVD CV: Reg rate, normal S1, S2. No m/r/g. CHEST: b/l wheezes and rhonchi. ABD: Soft, NT, ND, no HSM EXT: No c/c/e SKIN: maculopapular rash on back|IMPRESSION: No evidence of hemorrhage seen. Appearance of the brain is unchanged from . Opacification of visualized right maxillary sinus unchanged.|GRAYSCALE IMAGING: The liver demonstrates a heterogeneous echotexture without focal mass lesion detected on this limited evaluation of the hepatic parenchyma. No intra- or extra-hepatic biliary ductal dilatation with the common duct measuring 3 mm. The gallbladder appears unremarkable, without wall thickening or pericholecystic fluid/intraluminal stone. There is splenomegaly with the spleen measuring 17.6 cm. No intra-abdominal ascites. DOPPLER EXAMINATION: Color and pulsed pulse-wave Doppler images were obtained. The main portal vein is patent with normal hepatopetal flow with a velocity of 22 cm/sec. The TIPS shunt is patent with wall-to-wall flow. Velocities of 27, 90 and 94 cm/sec. The splenic vein and SMV are patent. IVC demonstrates patency with triphasic waveforms. IMPRESSION: Normal TIPS evaluation with wall-to-wall flow. No ascites identified.|# Respiratory failure:  The patient developed respiratory failure during seziure activity and recent HCAP.  He was intubated for airway protection and sent to the MICU.  He was able to be extubated days later without difficulty.  The patient was treated with lasix for diuresis.  Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course.|He was evaluated by pulmonary who felt his tachypnea was likely due to fluid overload. He was diuresed and his respiratory status later stabilized. No further bronchoscopy was recommended as it was unlikely that he laryngeal/tracheal stenosis given his clinical improvement with diuresis. . #Seizure disorder:  The patient has a known seizure disorder and hx of NCSE.  He again had continuous seizure activity documented by continous EEG monitoring.  His home regimen of keppra, zonegran and topamax was increased and ativan, dilantin were added to the regimen. He required dilantin loading on two occassions. His seizures were eventually well controlled and the ativan was weaned off without seizure recurrence under EEG monitoring. His mental status started to improve signficantly and at discharge, he was answering questions briskly, able to state the place but did not know the date, and was eager to leave the hospital. . # Cirrhosis: Secondary to NASH.  During his hospital stay his LFTs/bili and coags remained stable.  He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.  He was continued on lactulose and rifaxamin. . #. Stage IV sacral decub:  No evidence of osteomyelitis per X-ray.  Wound care consulted and recommended daily packing. . #DM: The patient was temporarily taken off home lantus as had episodes of hypoglycemia.  He was restarted on his home dose of lantus without problem. . #Hypothyroidism: continued home levothyroxine . # Hypernatremia:  The patient became transiently hypernatremic during his MICU course.  Free water boluses were increased through his tube feeds.  The hypernatremia resolved. . # CAD: stress MIBI in  w/ Fixed, medium sized, severe perfusion defect involving the PDA territory.  Increased left ventricular cavity size. Inferior hypokinesis with preserved systolic function.  No recent h/o chest pain.  Most recent echo with improved EF. . # Pancytopenia:  Chronic issue, likely BM suppression or secondary to seizure medications.  Trended, remained stable. . #FEN:  tube feeds, repleted electrolytes prn, free H20 boluses through tube feeds. #PPX: PPI, lactulose, pneumoboots (no heparin sq given low platelets), aspiration precautions, contact  #: Full Code #Communication: with wife  (-home) and -cell)|One (1) Tablet PO DAILY (Daily).|. Ascorbic Acid 500 mg Tablet : One (1) Tablet PO BID (2 times a day).|. Zinc Sulfate 220 mg Capsule : One (1) Capsule PO DAILY (Daily).|. Aspirin 325 mg Tablet : One (1) Tablet PO DAILY (Daily).|. Oxycodone 5 mg Tablet : 0.5 Tablet PO Q6H (every 6 hours) as needed: before sacral ulcer dressing.|0. Nystatin 100,000 unit/mL Suspension : Five (5) ML PO TID (3 times a day).|1. Lansoprazole 30 mg Tablet,Rapid Dissolve, DR : One (1) Tablet,Rapid Dissolve, DR  DAILY (Daily).|2. Miconazole Nitrate 2 % Powder : One (1) Appl Topical TID (3 times a day) as needed for tinea cruris.|3. Levetiracetam 1,000 mg Tablet : Two (2) Tablet PO BID (2 times a day).|4. Keppra 250 mg Tablet : One (1) Tablet PO twice a day.|5. Zonisamide 100 mg Capsule : Six (6) Capsule PO DAILY (Daily).|6. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization : One (1) neb Inhalation Q4H (every 4 hours) as needed for wheeze.|7. Ipratropium Bromide 0.02 % Solution : One (1) neb Inhalation Q6H (every 6 hours) as needed for wheeze.|8. Erythromycin 5 mg/g Ointment : One (1) application Ophthalmic QID (4 times a day).|9. Lactulose 10 gram/15 mL Syrup : Fifteen (15) ML PO TID (3 times a day): titrate to  BM per day.|0. Phenytoin 50 mg Tablet, Chewable : Four (4) Tablet, Chewable PO DAILY (Daily): Give in AM.|1. Phenytoin 50 mg Tablet, Chewable : Six (6) Tablet, Chewable PO DAILY (Daily): Give 8 pm.|2. Topiramate 100 mg Tablet : Three (3) Tablet PO BID (2 times a day).|3. Povidone-Iodine 10 % Solution : One (1) Appl Topical DAILY (Daily): apply to PEG tube insertion site.|4. Insulin Glargine 100 unit/mL Cartridge : Thirty Eight (38) Units Subcutaneous at bedtime.|5. Insulin Regular Human 300 unit/3 mL Insulin Pen : 11-32 units  Subcutaneous three times a day: Per sliding scale: FS 71-100, 11 Units FS 101-150, 17 Units FS 151-200, 20 Units FS 201-250, 24 Units FS 251-300, 28 Units FS 301-350, 32 Units.|increased seizure frequency in the context of PNA|NASH DM refractory seizures recurrent hepatic encephalopathy|stable; baseline MS difficulty with some memory and attention deficits. Distal extremity contractures, and asteryxis.|You were admitted with worsening seizures and mental status in the context of acquiring a pneumonia. You required temporary intubation and were treated with antibiotics. Your seizures were controlled with a combination of anti-epileptic medicines, which you should continue. Please return to the ER if you experiece any worsening of your seizure frequency, develop new types of seizures, develop changes in mental status, weakness, changes in sensation, vision, or language, and severe headaches, vertigo, or anything else that concerns you seriously.|Follow up with neurologist Dr.  ; call ( for appt']",During his hospital stay his LFTs/bili and coags remained stable. He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified. He was continued on lactulose and rifaxamin. During his hospital stay his LFTs/bili and coags remained stable. He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified. He was continued on lactulose and rifaxamin. During his hospital stay his LFTs/bili and coags remained stable. He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified. He was continued on lactulose and rifaxamin. During his hospital stay his LFTs/bili and coags remained stable. He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified. He was continued on lactulose and rifaxamin. During his hospital stay his LFTs/bili and coags remained stable. He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified. He was continued on lactulose and rifaxamin. During his hospital stay his LFTs/bili and coags remained stable. He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.,['During his hospital stay his LFTs/bili and coags remained stable.  He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow. No ascites identified.  He was continued on lactulose and rifaxamin.'],0.9999999999,0.5,0.817856512599088,1.0,0.25396825396825395,1.0,True
